Trial intelligence / Profile preview

Evaluation of oral chloral hydrate versus intranasal midazolam for sedation in children with head trauma

IRCT20180129038549N4Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of chloral hydrate and midazolam in traumatic brain injury (TBI) (2 arms), sponsored by Isfahan University of Medical Sciences. Started Sep 2017; status: completed.

02

Drugs

chloral hydratemidazolam
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on IRCT20180129038549N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180129038549N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call